Distribution deal launches unique New Zealand dairy ingredient into Japanese market New Zealand-based dairy biotechnology company announces distribution of patented milk protein ingredient into Japan. Also available in North America, IDP® offers unique antibacterial, anti-inflammatory and antioxidant benefits.
HAMILTON, New Zealand, June 25, 2013 /PRNewswire-iReach/ -- New Zealand-based dairy biotechnology company, Quantec Ltd, has signed a distribution and supply agreement with a major Japanese specialty ingredients company, Kanematsu Chemicals Corporation.
Kanematsu will distribute Quantec's patented complex of bioactive milk proteins called IDP® throughout Japan.
IDP® is also available for supply in North America – marketed directly by Quantec in New Zealand - and is approved for use in dietary supplements.
Quantec's Japanese deal is expected to extend over a number of years and the distribution agreement provides Quantec further expansion into the Asian market and provides Kanematsu with access to a unique New Zealand dairy-based bioactive protein ingredient for inclusion into Japanese functional foods and human health products.
"Japanese consumers have always looked very favorably on New Zealand dairy products and we expect the agreement between Quantec and Kanematsu to further build on this customer perception of quality and innovation," according to James Groenhart of Kanematsu New Zealand Ltd, who is a spokesman for the Japanese company.
Quantec has completed a number of clinical studies in the United States on IDP® over the past 5 years. These studies have investigated the complementary effect of IDP® on the human innate immune system (also known as non-specific immune system or "first line of defense") and the ability for IDP® to correctly control the size or amplitude of the immune response after injury or infection.
Founder and Managing Director of Quantec Ltd, Dr Rod Claycomb explains that, "IDP® is a unique ingredient naturally derived from fresh milk. It contains what we refer to as 'Triple-A' activity - antibacterial, anti-inflammatory and antioxidant. These bioactive proteins, which tend to resist much of the digestive process; work synergistically to destroy pathogenic bacteria, dampen the inflammatory response that often follows the infection or tissue damage and then completes the cycle by helping to promote the healing process. We have conducted studies using IDP® on subjects with systemic inflammation from arthritis, acne infections of the face and bacterial halitosis of the oral cavity, every time IDP® was shown to have a significant clinical advantage."
Founded in 2007, Quantec is unlike many other dairy-based companies in New Zealand who manufacture and market dairy commodities like milk powder, Quantec is focused on the discovery and commercialization of high-value bioactive compounds from milk.
About Quantec Ltd
Based at the Waikato Innovation Park in Hamilton, New Zealand, Quantec is a company specializing in the discovery and commercialization of high-value bioactives from natural products. Quantec discovered and patented its novel milk fraction, comprised of native immune defense proteins (IDP®), that has proven antimicrobial and anti-inflammatory properties. www.quantec.co.nz
Dr Rod Claycomb
Waikato Innovation Park, Hamilton, New Zealand
Ph +64 21 527 032
Media Contact: Grant Washington-Smith, Quantec Ltd, +64 6 352 0113, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Quantec Ltd